Search research articles
Contact Us
Filters
Showing results (111-120 of 213) with videos related to
Page
of 22
Sort By:
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique
|
January 1, 1986
[Physiology and physiopathology of calcitonin in man]
J J Body, A Borkowski, J Corvilain, et al.
Journal of Bone Oncology
|
November 19, 2015
Gorham-Stout disease of the proximal fibula treated with radiotherapy and zoledronic acid
V V Yerganyan, J J Body, N De Saint Aubain, et al.
Bone
|
January 1, 1991
Effects of Carbetimer, a new antineoplastic drug, on bone metabolism
J J Body, S Nejai, G Fernandez, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 1, 1986
Calcitonin deficiency in primary hypothyroidism
J J Body, N Demeester-Mirkine, A Borkowski, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
December 1, 1989
Aminohydroxypropylidene bisphosphonate (APD) treatment for tumor-associated hypercalcemia: a randomized comparison between a 3-day treatment and single 24-hour infusions
J J Body, A Magritte, F Seraj, et al.
The American Journal of Medicine
|
May 1, 1987
Dose/response study of aminohydroxypropylidene bisphosphonate in tumor-associated hypercalcemia
J J Body, M Pot, A Borkowski, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 1, 1999
A dose-finding study of zoledronate in hypercalcemic cancer patients
J J Body, A Lortholary, G Romieu, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 8, 2001
Breast cancer cells release factors that induced apoptosis in human bone marrow stromal cells
O Fromigué, N Kheddoumi, A Lomri, et al.
Clinical and Experimental Rheumatology
|
February 13, 2009
Renal tolerability of intermittent intravenous ibandronate treatment for patients with postmenopausal osteoporosis: a review
P D Miller, P Ward, T Pfister, et al.
Clinical Rheumatology
|
January 1, 1997
Retrobulbar optic neuritis after pamidronate administration in a patient with a history of cutaneous porphyria
J M des Grottes, M Schrooyen, J C Dumon, et al.
Page
of 22
Search research articles
Search
Showing results (111-120 of 213) with videos related to
Sort By:
Page
of 22
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique
|
January 1, 1986
[Physiology and physiopathology of calcitonin in man]
J J Body, A Borkowski, J Corvilain, et al.
Journal of Bone Oncology
|
November 19, 2015
Gorham-Stout disease of the proximal fibula treated with radiotherapy and zoledronic acid
V V Yerganyan, J J Body, N De Saint Aubain, et al.
Bone
|
January 1, 1991
Effects of Carbetimer, a new antineoplastic drug, on bone metabolism
J J Body, S Nejai, G Fernandez, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 1, 1986
Calcitonin deficiency in primary hypothyroidism
J J Body, N Demeester-Mirkine, A Borkowski, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
December 1, 1989
Aminohydroxypropylidene bisphosphonate (APD) treatment for tumor-associated hypercalcemia: a randomized comparison between a 3-day treatment and single 24-hour infusions
J J Body, A Magritte, F Seraj, et al.
The American Journal of Medicine
|
May 1, 1987
Dose/response study of aminohydroxypropylidene bisphosphonate in tumor-associated hypercalcemia
J J Body, M Pot, A Borkowski, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 1, 1999
A dose-finding study of zoledronate in hypercalcemic cancer patients
J J Body, A Lortholary, G Romieu, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 8, 2001
Breast cancer cells release factors that induced apoptosis in human bone marrow stromal cells
O Fromigué, N Kheddoumi, A Lomri, et al.
Clinical and Experimental Rheumatology
|
February 13, 2009
Renal tolerability of intermittent intravenous ibandronate treatment for patients with postmenopausal osteoporosis: a review
P D Miller, P Ward, T Pfister, et al.
Clinical Rheumatology
|
January 1, 1997
Retrobulbar optic neuritis after pamidronate administration in a patient with a history of cutaneous porphyria
J M des Grottes, M Schrooyen, J C Dumon, et al.
Page
of 22